Oculus Innovative Sciences to price public sale of 5.75 million units

Funds to be used to increase direct sales force, launch new products

By Devika Patel

Knoxville, Tenn., Jan. 16 – Oculus Innovative Sciences, Inc. will sell 5.75 million units in its public offering with a 45-day greenshoe option of 862,500 additional units, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced Nov. 21.

The units will each consist of one common share and 0.75 five-year warrants.

Maxim Group, LLC is the bookrunner. Dawson James Securities, Inc. is the co-manager.

Proceeds will be used to increase the company’s direct sales force, to develop and launch new products and for general working capital.

Oculus is a specialty pharmaceutical company based in Petaluma, Calif., that develops and markets solutions for the treatment of dermatological conditions and tissue care. The company said it intends to apply for listing of the warrants on the Nasdaq Capital Market.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.